Sort
4,870 grants matching “glp 1”
Human Antibody Therapeutics Against Anthrax
$737,620Alexion Pharmaceuticals, Inc. · U01 · FY2004 · AI
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity
$736,762Jennifer E Van Eyk · Cedars-Sinai Medical Center · U01 · FY2020 · DK
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity
$736,762Jennifer E Van Eyk · Cedars-Sinai Medical Center · U01 · FY2022 · DK
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity
$736,762Jennifer E Van Eyk · Cedars-Sinai Medical Center · U01 · FY2021 · DK
Nrf2 and the expansion and preservation of beta cell mass
$735,808Donald K Scott · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
$734,917Pankaj Arora · University Of Alabama At Birmingham · R01 · FY2022 · HL
Development and Pre-Clinical Trial Qualification of a Pediatric Pump-Lung System for Children
$734,866Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2018 · HL
New tools from chemistry and antibodies to address receptor function
$734,542Ross Cheloha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain
$734,315Jeff Mark Herz · Algomedix, Inc. · R44 · FY2017 · DA
Pathogenesis of youth onset pre diabetes and Type 2 diabetes.
$734,178Sonia Caprio · Yale University · R01 · FY2016 · DK
Pathogenesis of youth onset pre-diabetes and Type 2 diabetes
$733,481Sonia Caprio · Yale University · R01 · FY2024 · DK
Molecular Antecedents of Miscarriage
$733,193Raina N Fichorova · Brigham And Women'S Hospital · R01 · FY2024 · HD
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
$733,166Bruce Dale Weintraub · Trophogen, Inc. · R44 · FY2019 · HD
Pathogenesis of youth onset pre diabetes and Type 2 diabetes.
$732,218Sonia Caprio · Yale University · R01 · FY2018 · DK
Pathogenesis of youth onset pre diabetes and Type 2 diabetes.
$732,218Sonia Caprio · Yale University · R01 · FY2017 · DK
Challenges to Guideline-Recommended Diabetes Care in the United States
$731,071Jung-Im Shin · Johns Hopkins University · R01 · FY2025 · DK
Adipocyte-Eosinophil Communication and Its Role in Regulation of Airway Function
$730,392Sergejs Berdnikovs · University Of Colorado Denver · R01 · FY2025 · AI
SuperGAGs for Intravesicular Treatment of Interstitial Cystitis
$730,062Robert Evan Hurst · Glycologix, Llc · R44 · FY2020 · DK
Adenosine-3 agonists for the suppression of arthritis
$730,027Inotek Pharmaceuticals Corporation · R44 · FY2002 · AR
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function
$729,375Sven M Karlsson · Stellular Bio, Inc. · R44 · FY2016 · HL
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function
$729,375Sven M Karlsson · Stellular Bio, Inc. · R44 · FY2017 · HL
Development of a Counterpulsation Therapy Device
$728,749Paul A Spence · Scr, Inc. · R44 · FY2009 · HL
Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetes
$728,612Gerald I Shulman · Yale University · R01 · FY2024 · DK
Development of Fibrin-Specific Nuclear Probe to Reduce LVAD Adverse Events
$728,200James Blackledge · Capella Imaging, Llc · R42 · FY2019 · HL
Studies in Youths & Young Adults with Obesity & T2DM (07-DK-0115, 10-DK-0163)
$727,715James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK